Mechanisms Linking Sleep-Disordered Breathing and Cardiometabolic Disease Risk

Area of Science:

• Cardiology
• Pulmonology
• Metabolic Health

Background:

• Sleep-disordered breathing (SDB) involves airway narrowing or closure, impacting cardiovascular and metabolic health.
• Growing evidence links SDB's physiological changes to adverse cardiometabolic outcomes.
• SDB affects autonomic function, inflammation, sleep quality, and oxidative stress.

Purpose of the Study:

• To review the mechanisms by which SDB increases cardiometabolic disease risk.
• To discuss current SDB therapies and their targets for risk mitigation.

Main Methods:

• Review of existing literature on SDB and cardiometabolic disease.
• Analysis of physiological pathways affected by SDB.
• Examination of therapeutic interventions for SDB.

Main Results:

• SDB-induced pathways include autonomic dysfunction, inflammation, oxidative stress, and altered gene expression.
• These pathways contribute to hypertension, vascular dysfunction, insulin resistance, and weight gain.
• SDB treatments can alleviate symptoms and reduce cardiometabolic risk.

Conclusions:

• SDB poses a significant risk to cardiovascular and metabolic health through multiple interconnected mechanisms.
• Therapeutic interventions for SDB offer potential for mitigating these risks.
• Further research into SDB mechanisms and targeted therapies is warranted.